| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
in00005771202 |
| 005 |
20260327173922.5 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
230202t20232023enk ob 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d OPELS
|d YDX
|d OCLCF
|d TFW
|d OCLCO
|d CLOUD
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9780443187452
|q electronic book
|
| 020 |
|
|
|a 0443187452
|q electronic book
|
| 020 |
|
|
|z 9780443187445
|
| 035 |
|
|
|a (OCoLC)1365333836
|
| 050 |
|
4 |
|a RC123.C3
|b K85 2023
|
| 082 |
0 |
4 |
|a 616.9693061
|2 23/eng/20230220
|
| 049 |
|
|
|a TXAM
|
| 100 |
1 |
|
|a Kumar, Awanish,
|e author.
|1 https://id.oclc.org/worldcat/entity/E39PCjGqGY7qvcwdhPjpGyDCV3
|
| 245 |
1 |
0 |
|a Anticandidal therapeutics :
|b discovery and development /
|c Awanish Kumar, Anubhuti Jha.
|
| 264 |
|
1 |
|a London, United Kingdom ;
|a San Diego, CA, United States ;
|a Cambridge, MA, United States ;
|a Kidlington, Oxford, United Kingdom :
|b Elsevier, Academic Press, an Imprint of Elsevier,
|c [2023]
|
| 264 |
|
4 |
|c ©2023
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
0 |
|
|a Developments in microbiology
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on online resource; title from digital title page (viewed on March 10, 2023).
|
| 520 |
|
|
|a Developments of antifungal agents have declined as compared to other antibiotics that have displayed a potent development with time. There is an urgent need for both prophylactic and therapeutic treatments worldwide to control the severity of infections caused by Candida. Anticandidal Therapeutics: Discovery and Development provides the readers with a compiled knowledge of the fungal human infection Candida and the development of anticandidal drugs. Anticandidal Therapeutics helps researchers form the basis for the discovery and development of novel anticandidal therapies. In 14 chapters this book provides collective information on anticandidal agents and their discovery and development with respect to major drug transporter families, different stages of anticandidal agent development, recent trends and progress in antifungal translational research, clinical studies status of anticandidal therapeutic agents, and drug repurposing for development of novel anticandidal agents. Highlights the mechanistic actions of some therapeutic agents against Candida Focuses on anticandidal agents rather than general antifungal agents Discusses the stage of development of new antifungal drugs, the repositioning of drugs, and how this could help in treatment.
|
| 650 |
|
0 |
|a Candidiasis
|x Chemotherapy.
|
| 650 |
|
0 |
|a Candida.
|
| 650 |
|
2 |
|a Candida
|
| 650 |
|
6 |
|a Candidose
|x Chimiothérapie.
|
| 650 |
|
6 |
|a Candida.
|
| 650 |
|
7 |
|a Microbiology.
|2 bisacsh
|
| 650 |
|
7 |
|a Mycology.
|2 bisacsh
|
| 650 |
|
7 |
|a Life Sciences.
|2 bisacsh
|
| 650 |
|
7 |
|a SCIENCE.
|2 bisacsh
|
| 650 |
|
7 |
|a Candida
|2 fast
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 700 |
1 |
|
|a Jha, Anubhuti,
|e author.
|1 https://id.oclc.org/worldcat/entity/E39PCjK4fmjbBhbqdcYKRtGwT3
|
| 710 |
2 |
|
|a ScienceDirect (Online service)
|
| 776 |
0 |
8 |
|c Original
|z 0443187444
|z 9780443187445
|w (OCoLC)1321787283
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://www.sciencedirect.com/science/book/9780443187445
|z Connect to the full text of this electronic book
|t 0
|
| 955 |
|
|
|a Elsevier ScienceDirect 2026-2027
|
| 994 |
|
|
|a 92
|b TXA
|
| 999 |
f |
f |
|i a0f90257-ed4a-4a7b-a98f-6f172e48971f
|s 5ed87d4a-60d8-40ec-8e15-96f2f2f045c3
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|s www_evans
|d Available Online
|t 0
|e RC123.C3 K85 2023
|h Library of Congress classification
|
| 998 |
f |
f |
|a RC123.C3 K85 2023
|t 0
|l Available Online
|